Role of HNF-1A in the regulation of UGT1A1, UGT1A9 and UGT2B7 MRNA expression.

被引:0
|
作者
Mirkov, S [1 ]
Innocenti, F [1 ]
Liu, W [1 ]
Chen, PX [1 ]
Ramirez, J [1 ]
Undevia, SD [1 ]
Das, S [1 ]
Ratain, MJ [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.clpt.2004.12.125
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P61 / P61
页数:1
相关论文
共 50 条
  • [1] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver
    Ramirez, J.
    Mirkov, S.
    Zhang, W.
    Chen, P.
    Das, S.
    Liu, W.
    Ratain, M. J.
    Innocenti, F.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (02): : 152 - 161
  • [2] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver
    J Ramírez
    S Mirkov
    W Zhang
    P Chen
    S Das
    W Liu
    M J Ratain
    F Innocenti
    The Pharmacogenomics Journal, 2008, 8 : 152 - 161
  • [3] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver.
    Mirkov, S.
    Ramirez, J.
    Zhang, W.
    Chen, P.
    Das, S.
    Liu, W.
    Ratain, M. J.
    Innocenti, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S61 - S61
  • [4] The UGT1A9 intronic 1399 polymorphism is not associated with UGT1A9 activity or mRNA expression.
    Ramirez, J.
    Liu, W.
    Desai, A. A.
    Mirkov, S.
    Chen, P.
    Das, S.
    Innocenti, F.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S87 - S87
  • [5] Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
    Peterkin, Vincent C.
    Bauman, Jonathan N.
    Goosen, Theunis C.
    Menning, Lee
    Man, Michael Z.
    Paulauskis, Joseph D.
    Williams, J. Andrew
    Myrand, Scott P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 458 - 468
  • [6] Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
    Matsumoto, Jun
    Nishimoto, Anzu
    Watari, Shogo
    Ueki, Hideo
    Shiromizu, Shoya
    Iwata, Naohiro
    Takeda, Tatsuaki
    Ushio, Soichiro
    Kajizono, Makoto
    Fujiyoshi, Masachika
    Koyama, Toshihiro
    Araki, Motoo
    Wada, Koichiro
    Zamami, Yoshito
    Nasu, Yasutomo
    Ariyoshi, Noritaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (08) : 1779 - 1790
  • [7] Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
    Jun Matsumoto
    Anzu Nishimoto
    Shogo Watari
    Hideo Ueki
    Shoya Shiromizu
    Naohiro Iwata
    Tatsuaki Takeda
    Soichiro Ushio
    Makoto Kajizono
    Masachika Fujiyoshi
    Toshihiro Koyama
    Motoo Araki
    Koichiro Wada
    Yoshito Zamami
    Yasutomo Nasu
    Noritaka Ariyoshi
    Molecular and Cellular Biochemistry, 2023, 478 : 1779 - 1790
  • [8] Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
    Hiromichi Maeda
    Shoichi Hazama
    Abdiev Shavkat
    Ken Okamoto
    Koji Oba
    Junichi Sakamoto
    Kenichi Takahashi
    Masaki Oka
    Daisuke Nakamura
    Ryouichi Tsunedomi
    Naoko Okayama
    Hideyuki Mishima
    Michiya Kobayashi
    Molecular Diagnosis & Therapy, 2014, 18 : 333 - 342
  • [9] Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
    Maeda, Hiromichi
    Hazama, Shoichi
    Shavkat, Abdiev
    Okamoto, Ken
    Oba, Koji
    Sakamoto, Junichi
    Takahashi, Kenichi
    Oka, Masaki
    Nakamura, Daisuke
    Tsunedomi, Ryouichi
    Okayama, Naoko
    Mishima, Hideyuki
    Kobayashi, Michiya
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (03) : 333 - 342
  • [10] Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk
    McGrath, Monica
    Lepine, Johanie
    Lee, I-Min
    Villeneuve, Lyne
    Buring, Julie
    Guillemette, Chantal
    De Vivo, Immaculata
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (03): : 239 - 243